Five faculty members in the UAB School of Medicine have been named the inaugural James A. Pittman Jr., M.D., Scholars, a new program organized to recognize the contributions of junior faculty.
Precious time is lost waiting for laboratory test results for people battling this infection. With the help of medical device startup Kypha Inc., one UAB researcher’s work could change this.
The multi-project research targets key molecular steps of immune cell-fate decisions after virus infection.
A study reveals a potential new drug pathway target for battling Mycobacterium tuberculosis, or Mtb, the pathogen that causes tuberculosis.
Gail Cassell, Ph.D., former chair of the Department of Microbiology, told researchers at the 5th biennial Southeastern Mycobacteria Meeting at UAB that less than 10 percent of drug-resistant tuberculosis cases are being treated and untreated patients continue to spread the disease.
Adrie Steyn, Ph.D., examines tuberculosis through his joint appointments at the KwaZulu-Natal Research Institute for Tuberculosis and HIV in Durban, South Africa and the UAB Department of Microbiology.
The Department of Microbiology and the Center for AIDS Research hosted 100 researchers at the 5th biennial Southeastern Mycobacteria meeting in January.
Professor of Microbiology David Briles, Ph.D., and Professor of Optometry Lawrence DeLucas, O.D., Ph.D., will be inducted into the NIA, professional distinction accorded to academic inventors.
Microbiology Professor John Kearney's research in monoclonal antibodies led to treatments for breast cancer, rheumatoid arthritis and more during his 40 years at UAB and earned him selection as the 2013 Distinguished Faculty Lecturer.
Fast, inexpensive gene sequencing needed to make possible personalized medicine.